Peripartum Outcomes: Non-Adjuvanted v. Adjuvanted H1N1 Vaccination

CMAJ - Canada
doi 10.1503/cmaj.114-0006
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Joule Inc.

Related search

Influenza Vaccination in Children Primed With MF59®-adjuvanted or Non-Adjuvanted Seasonal Influenza Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2015English

Safe Vaccination of Patients With Egg Allergy With an Adjuvanted Pandemic H1N1 Vaccine

Pediatrics
Child HealthPediatricsPerinatology
2011English

Comparison of the Adverse Events Associated With MF59-Adjuvanted and Non-Adjuvanted H1N1 Vaccines in Healthy Young Male Korean Soldiers

Japanese Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2012English

Obesity Outweighs Protection Conferred by Adjuvanted Influenza Vaccination

mBio
VirologyMicrobiology
2016English

Influenza a/H1n1 MF59 Adjuvanted Vaccine in Pregnant Women and Adverse Perinatal Outcomes: Multicentre Study

British Medical Journal
Medicine
2013English

Humoral and Cellular Responses to a Non-Adjuvanted Monovalent H1N1 Pandemic Influenza Vaccine in Hospital Employees

BMC Infectious Diseases
Infectious Diseases
2013English

The Responses of Aboriginal Canadians to Adjuvanted Pandemic (H1N1) 2009 Influenza Vaccine

CMAJ
Medicine
2011English

Safety of AS03-adjuvanted Split-Virion H1N1 (2009) Pandemic Influenza Vaccine: A Prospective Cohort Study

BMJ Open
Medicine
2013English

Cost-Effectiveness of 2-Dose AS04-Adjuvanted Human Papillomavirus 16/18 Vaccination Schedule in Slovakia

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy